US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CERT

Certara (CERT)

Certara Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CERT

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/05/2024	15:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CERT	Certara Inc
07/05/2024	15:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CERT	Certara Inc
07/05/2024	15:15	GlobeNewswire Inc.	Certara Reports First Quarter 2024 Financial Results	NASDAQ:CERT	Certara Inc
16/04/2024	07:00	GlobeNewswire Inc.	Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform	NASDAQ:CERT	Certara Inc
09/04/2024	15:15	GlobeNewswire Inc.	Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference	NASDAQ:CERT	Certara Inc
06/03/2024	15:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CERT	Certara Inc
04/03/2024	18:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CERT	Certara Inc
29/02/2024	15:30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CERT	Certara Inc
29/02/2024	15:10	GlobeNewswire Inc.	Certara Reports Fourth Quarter 2023 Financial Results	NASDAQ:CERT	Certara Inc
01/02/2024	15:30	GlobeNewswire Inc.	Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference	NASDAQ:CERT	Certara Inc
13/12/2023	15:30	GlobeNewswire Inc.	Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies	NASDAQ:CERT	Certara Inc
21/11/2023	15:30	GlobeNewswire Inc.	Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development	NASDAQ:CERT	Certara Inc
08/11/2023	15:10	GlobeNewswire Inc.	Certara Reports Third Quarter 2023 Financial Results	NASDAQ:CERT	Certara Inc
11/10/2023	15:15	GlobeNewswire Inc.	Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference	NASDAQ:CERT	Certara Inc
19/09/2023	07:15	GlobeNewswire Inc.	Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software	NASDAQ:CERT	Certara Inc
29/08/2023	15:15	GlobeNewswire Inc.	Certara to Participate in Upcoming Investor Conferences	NASDAQ:CERT	Certara Inc
29/08/2023	07:15	GlobeNewswire Inc.	Certara Simcyp™ Group Awarded Two New Grants from US FDA	NASDAQ:CERT	Certara Inc
09/08/2023	15:15	GlobeNewswire Inc.	Certara Reports Second Quarter 2023 Financial Results	NASDAQ:CERT	Certara Inc
03/08/2023	20:00	Business Wire	Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset	NASDAQ:CERT	Certara Inc
13/07/2023	15:30	GlobeNewswire Inc.	Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023	NASDAQ:CERT	Certara Inc
02/06/2023	15:15	GlobeNewswire Inc.	Certara to Participate in the Jefferies Global Healthcare Conference	NASDAQ:CERT	Certara Inc
25/05/2023	15:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CERT	Certara Inc
25/05/2023	07:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CERT	Certara Inc
11/05/2023	11:15	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:CERT	Certara Inc
08/05/2023	15:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CERT	Certara Inc
08/05/2023	15:15	GlobeNewswire Inc.	Certara Reports First Quarter 2023 Financial Results	NASDAQ:CERT	Certara Inc
27/04/2023	07:00	GlobeNewswire Inc.	Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year	NASDAQ:CERT	Certara Inc
10/04/2023	15:30	GlobeNewswire Inc.	Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference	NASDAQ:CERT	Certara Inc
10/04/2023	05:03	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:CERT	Certara Inc
10/04/2023	05:02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CERT	Certara Inc

Showing the most relevant articles for your search:NASDAQ:CERT

1 2 3 4 5 Próxima >

L&G Healthcare Breakthro...

Umami Sustainable Seafood (CE)

Generation Asia I Acquis... (PK)

Cyxtera Technologies (CE)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones